A new dramatic series revolving around China’s battle against the Covid-19 pandemic is featured in the market screenings of Singapore’s Asia TV Forum (Atf). The series takes pride of place as part of the Middle Kingdom’s most elaborate presence at virtual markets this year.
“With You” is a 20-episode anthological drama series featuring 10 fact-based stories about Chinese civilians’ battle against the coronavirus outbreak, said organizers. An on-demand industry preview is featured at the online fair which runs from December 1 to 4.
The series, produced by Shanghai Media Group, Youhug Media and Smg Pictures, is part of the pavilion’s “Focus on China” presentation, which organizers said is the first of its kind as a title brand sponsor, and marks “the 30th anniversary of the establishment of diplomatic relations between China and Singapore. Six events including the market screening of “With You” and presentations of other fresh content, will take place under the banner.
“With You” is a 20-episode anthological drama series featuring 10 fact-based stories about Chinese civilians’ battle against the coronavirus outbreak, said organizers. An on-demand industry preview is featured at the online fair which runs from December 1 to 4.
The series, produced by Shanghai Media Group, Youhug Media and Smg Pictures, is part of the pavilion’s “Focus on China” presentation, which organizers said is the first of its kind as a title brand sponsor, and marks “the 30th anniversary of the establishment of diplomatic relations between China and Singapore. Six events including the market screening of “With You” and presentations of other fresh content, will take place under the banner.
- 12/1/2020
- by Vivienne Chow
- Variety Film + TV
IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news articles, Tweets, and blog posts do not represent IMDb's opinions nor can we guarantee that the reporting therein is completely factual. Please visit the source responsible for the item in question to report any concerns you may have regarding content or accuracy.